The Naloxone Hydrochloride Intranasa, cataloged under National Stock Number 6505-01-714-2921, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Emergent Devices, Inc.. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BX.
| Parameter | Value |
|---|---|
| NSN | 6505-01-714-2921 |
| Primary Part Number | NDC69547-0627-02 |
| Item Name | Naloxone Hydrochloride Intranasa |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Emergent Devices, Inc. |
| Status | ACTIVE |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BX |
| Part Number | Manufacturer |
|---|---|
| NDC69547-0627-02 PRIMARY | Emergent Devices, Inc. (USA) |
| Reference | Meaning |
|---|---|
| 6505NCM239288 | 5/1 Secondary reference Defense Medical Standardization Board |
| 1656529 | 5/1 Secondary reference U.S. Government activity |
| NARCAN OTC | 5/1 Secondary reference Emergent Devices, Inc. |
NSN 6505-01-714-2921 is a Naloxone Hydrochloride Intranasa, manufactured by Emergent Devices, Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-714-2921 has 1 manufacturer part number on file: NDC69547-0627-02 (Emergent Devices, Inc.).
Key specifications for NDC69547-0627-02: Special Features: NARCAN 4MG NASAL SPRAY 2 SINGLE-DOSE NASAL SPRAY DEVICES 0.003 FL OZ (0.1 ML) EACH. FOR USE IN NOSE ONLY. STORE AT ROOM TEMPERATURE OR REFRIGERATED, BETWEEN 2 C TO 25 C (36 F TO 77 F) DO NOT FREEZE; AVOID EXCESSIVE HEAT ABOVE DO NOT FREEZE; AVOID EXCESSIVE HEAT ABOVE 40 C (104 F NALOXONE HCL NASAL SPRAY 4 MG EMERGENCY TREATMENT OF OPIOID OVERDOSE. DESIGNED TO RAPIDLY REVERSE THE EFFECTS OF A LIFE-THREATENING OPIOID EMERGENCY.; Part Name Assigned by Controlling Agency: NALOXONE HYDROCHLORIDE INTRANASAL SPRAY 4MG SINGLE-DOSE NASAL SPRAY 2EA. 0 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.